Literature DB >> 24242875

Interleukin-7 receptor single nucleotide polymorphism rs6897932 (C/T) and the susceptibility to systemic lupus erythematosus.

Xiao-Song Wang1, Peng-Fei Wen, Min Zhang, Lin-Feng Hu, Jing Ni, Li-Juan Qiu, Yan Liang, Wei Zhao, Qing Huang, Sha-Sha Tao, Wang-Dong Xu, Chen-Chen Feng, Han Cen, Rui-Xue Leng, Hai-Feng Pan, Dong-Qing Ye.   

Abstract

Emerging evidences were accumulated to support the view that aberrant interleukin-7 (IL-7) signaling might be associated with autoimmunity. Former studies demonstrated the single nucleotide polymorphism (SNP) rs6897932 C/T in the IL-7 receptor (IL-7R) gene was associated with susceptibility to autoimmune diseases, including multiple sclerosis and type I diabetes. Given these, this study was conducted to investigate whether an association existed between SNP rs6897932 and the susceptibility to systemic lupus erythematosus (SLE), a severe systemic autoimmune disease. In this context, 816 SLE patients and 816 controls from a Chinese population were recruited for this study, and the results showed that the major allele C of rs6897932 showed a higher frequency in SLE patients compared with controls (P = 0.039, C versus T); significant difference was also detected under a recessive model with regard to the distribution of genotype frequencies between SLE patients and controls (P = 0.041, CC versus CT + TT), which was not consistent with the results under a dominant model (P = 0.349, CC + CT versus TT). Moreover, association studies were also performed contraposing the relationship between the SNP rs6897932 C/T and lupus nephritis as well as 10 clinical features of SLE; however, no significant association signal was found regarding the distribution of allele and genotype frequencies between SLE patients positive and negative for the presence of 11 sub-phenotypes. In conclusion, the major allele C of SNP rs6897932 may be associated with increased SLE risk in Chinese populations, and further studies are still encouraged to shed light on the true associations between SLE and its susceptibility genes with respect to IL-7R gene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24242875     DOI: 10.1007/s10753-013-9777-x

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

Review 1.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development.

Authors:  Changwan Hong; Megan A Luckey; Jung-Hyun Park
Journal:  Semin Immunol       Date:  2012-03-14       Impact factor: 11.130

4.  Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily.

Authors:  R G Goodwin; D Friend; S F Ziegler; R Jerzy; B A Falk; S Gimpel; D Cosman; S K Dower; C J March; A E Namen
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

5.  Lupus nephritis: Implications of the new ACR lupus nephritis guidelines.

Authors:  Hans-Joachim Anders; Gerald B Appel
Journal:  Nat Rev Nephrol       Date:  2012-07-24       Impact factor: 28.314

6.  Role of the intracellular domain of IL-7 receptor in T cell development.

Authors:  Qiong Jiang; Jiaqiang Huang; Wen Qing Li; Tiziana Cavinato; Jonathan R Keller; Scott K Durum
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

7.  Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.

Authors:  Nizar Chetoui; Marc Boisvert; Steve Gendron; Fawzi Aoudjit
Journal:  Immunology       Date:  2010-05-04       Impact factor: 7.397

8.  Structural and biophysical studies of the human IL-7/IL-7Ralpha complex.

Authors:  Craig A McElroy; Julie A Dohm; Scott T R Walsh
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

9.  Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.

Authors:  Wangko Lundström; Steven Highfill; Scott T R Walsh; Stephanie Beq; Elizabeth Morse; Ingrid Kockum; Lars Alfredsson; Tomas Olsson; Jan Hillert; Crystal L Mackall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

10.  Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade.

Authors:  Rosana Gonzalez-Quintial; Brian R Lawson; John C Scatizzi; Joseph Craft; Dwight H Kono; Roberto Baccala; Argyrios N Theofilopoulos
Journal:  PLoS One       Date:  2011-11-10       Impact factor: 3.240

View more
  6 in total

Review 1.  IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?

Authors:  Christian Lundtoft; Julia Seyfarth; Marc Jacobsen
Journal:  Genes Immun       Date:  2020-01-13       Impact factor: 2.676

2.  Association of rs12487066, rs12044852, rs10735781, rs3135388, rs6897932, rs1321172, rs10492972, and rs9657904 Polymorphisms with Multiple Sclerosis in Iranian Population.

Authors:  Takavar Razavian; Mahdieh Ebrahimi Shakib; Kurosh Gharagozli; Hossein Maghsoudi; Seyed Kazem Bidoki; Soha Sadeghi; Massoud Houshmand
Journal:  Oman Med J       Date:  2020-07-20

3.  Investigating Factors Associated with Thymic Regeneration after Chemotherapy in Patients with Lymphoma.

Authors:  Dao-Ping Sun; Li Wang; Chong-Yang Ding; Jin-Hua Liang; Hua-Yuan Zhu; Yu-Jie Wu; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  Front Immunol       Date:  2016-12-27       Impact factor: 7.561

Review 4.  Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent.

Authors:  Priscila O Barros; Tamara K Berthoud; Nawaf Aloufi; Jonathan B Angel
Journal:  Immunotargets Ther       Date:  2021-03-08

5.  Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus.

Authors:  Shuhong Chi; Jing Xue; Feng Li; Caixia Zhu; Yunxia Yu; Haibo Li; Xuemei Wang; Yurong Zhang; Jijuan Yang; Shaolan Zhou; Lijuan Yang; Chen Ji; Xiaoming Liu
Journal:  Autoimmune Dis       Date:  2016-03-16

6.  IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates.

Authors:  Lyssia Belarif; Caroline Mary; Lola Jacquemont; Hoa Le Mai; Richard Danger; Jeremy Hervouet; David Minault; Virginie Thepenier; Veronique Nerrière-Daguin; Elisabeth Nguyen; Sabrina Pengam; Eric Largy; Arnaud Delobel; Bernard Martinet; Stéphanie Le Bas-Bernardet; Sophie Brouard; Jean-Paul Soulillou; Nicolas Degauque; Gilles Blancho; Bernard Vanhove; Nicolas Poirier
Journal:  Nat Commun       Date:  2018-10-26       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.